100 percent in agreement here. It's not unusual for a growing company to have a share offering and increase the OS - can mean short-term pain, long-term gain. I've seen it a ton in the biotech sector in particular, when additional funding is needed to get through clinical trials, Phase II, Phase III before reaching the finish line of FDA approval.
Making money takes money. I don't see this as a horrible thing. I also don't know why everyone was insisting on Stocktwits that this would go to .0005, saying that a lot of the shares would be sold at that price. Looking at the 1-A, I see a 1 billion share offering at 1 cent per share, in an effort to raise $10 million, that would need to be orchestrated within 12 months. Open to any criticism/corrections on this understanding of the 1-A...
Where does it say some shares could be sold at .0005? I only see 1 cent. That made me wonder - what if the company DOES sell that property, like you suggested, at, say, $3.3 million in around April, when the market is generally a bit stronger. The stock won't stay stuck at .0015 or whatever...it could move. How do we know it couldn't go to, say, 1.5 cents, and THEN they do the dilution, and the people buying at a penny are getting a bargain? How much do we really know at this point? Instead, I think everyone is just making a snap judgment and saying the company is horrible, and the stock has dropped nearly 50 percent from the high on Wednesday - which almost bakes in the additional shares - which haven't even hit the market yet.
Nobody knows what's going to happen - but if people panic this back down to .0015ish, I'm thinking it would be a great buy and hold.
News 
Market Data 
Discover 
AI
